FireEye Vision Completes Nearly RMB 10 Million Angel Funding to Accelerate R&D in XR-Enabled Smart Ophthalmic Healthcare

Recently, Shenzhen Huoyanjing Medical Technology Co., Ltd. (referred to as "Huoyanjing") announced the completion of an angel round of financing worth nearly ten million yuan. This round of financing will accelerate Huoyanjing's research and development iteration and market expansion in the field of optometry XR intelligent medical technology, promoting myopia prevention and control technology for children and adolescents into a new stage of intelligence.

Shenzhen Huoyanjingjing Medical Technology Co., Ltd. was established in 2022, dedicated to building a digital optometry platform using XR+AI technology with the aim of addressing the imbalance in medical resources and bringing benefits to more patients with eye health issues. The company currently offers products such as the Huoyanjingjing Youth and Children VR Intelligent Vision Training Device M1, Adult Eye Fatigue and Presbyopia Intelligent Vision Training Device, and the Shilangqing VR Low Vision Intelligent Visual Aid.

The myopia rate among children and adolescents in China has remained persistently high. The three major trends in myopia among Chinese children and adolescents are: younger age of onset, faster progression of myopia, and an increasing proportion of children with high myopia. However, there are variations in the myopia conditions and coping methods for individual children and adolescents, making it crucial to propose personalized and innovative solutions. Intelligent optometry has become a key approach to addressing this issue.

The Fire Eyes Crystal VR Intelligent Vision Training Device M1 for Adolescents and Children is an intelligent visual health solution jointly developed by Fire Eyes Crystal and Zhongshan Ophthalmology. Relying on an integrated technology platform of "optics, mechanics, electronics, software, and algorithms," it provides myopia prevention, myopia control, and visual function examination services for children and adolescents aged 6-12.

This product adopts the globally leading Pancake short-focus optical technology, creating the thinnest and lightest near-eye ultra-distance product in the industry (with a total weight of only 160 grams). It is comfortable to wear, meeting national visual health safety standards and TUV anti-blue light certification, ensuring the safety of non-invasive training. Additionally, the product can design differentiated training programs based on the visual development characteristics of children at different ages, as well as individual visual function parameters. The accompanying optometry cloud system establishes exclusive vision records for children, tracking professional optometry data such as diopter, axial length, PRA/NRA, and generates personalized training plans through cloud-based big data analysis, achieving precise myopia prevention and control solutions that meet clinical standards.

Regarding the acquisition of this round of financing, Chen Wei, founder of Huoyanjingjing, stated: "The metaverse and digital healthcare have gone through the concept phase, exploration phase, and model validation phase over the past few years. Currently, we have officially entered the first year of AI + healthcare. Due to the vast market potential in the optometry field, the essential need for eye health among the population, the limitations of traditional diagnostic methods, and the inherent contradiction of inaccessible primary healthcare resources, achieving full-cycle management of national eye health must rely on digital and intelligent means to be resolved. In the future, Huoyanjingjing will collaborate with more experts to rapidly develop paradigms, conduct clinical validations, and promote market adoption for issues such as amblyopia, adult visual fatigue, and presbyopia, jointly advancing the transformation from clinical theory to product realization."